SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status

Journal of Hematology & Oncology (2009) - Comment
pubmed: 19220884 doi: 10.1186/1756-8722-2-8 issn: 1756-8722

Ayad M Al-Katib, Yuan Sun, Anton Scott Goustin, Asfar Sohail Azmi, Ben Chen, Amro Aboukameel, Ramzi M Mohammad